PLASMODIUM VIVAX INFECTION

This adverse event was reported 23 times

PLASMODIUM VIVAX INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRIMAQUINE PHOSPHATE 7 0.0805
1 TAFENOQUINE 2 0.0303
2 CHLOROQUINE PHOSPHATE 1 0.0015
3 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 2 0.0009
4 NITROUS OXIDE 1 0.0005
5 OXYTOCIN 1 0.0003
6 SALINE NASAL SPRAY 1 0.0002
7 PAROXETINE HYDROCHLORIDE 7 0.0002
8 GOLIMUMAB 2 0.0002
9 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 5 0.0001
See all drugs enriched for association with PLASMODIUM VIVAX INFECTION

PLASMODIUM VIVAX INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Oxytocic [EPC] 1 0.0003
1 Antimalarial [EPC] 2 0.0002
2 Antiprotozoal [EPC] 2 0.0002
3 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
4 Tetracycline-class Drug [EPC] 2 0.0000
5 Fluoroquinolone Antibacterial [EPC] 1 0.0000
6 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Vitamin B12 [EPC] 1 0.0000
See all drug classes enriched for association with PLASMODIUM VIVAX INFECTION